Liquid embolic therapies are increasingly being used to treat numerous medical conditions & ailments due to their minimally-invasive nature; these include vascular malformations, aneurysms & more recently even tumors. In this article, we will explore some of the latest trends and developments in the liquid embolic market that are driving growth across the industry.
The global liquid embolic market was valued at US$ 231.9 Mn in 2020, and is projected to experience a noteworthy 8.9% CAGR to reach a market valuation of approximately US$ 580.5 Mn by 2031.
Request For Free Sample Report of “Liquid Embolic Market”@ https://www.persistencemarketresearch.com/samples/25513
Firstly, advancements within digital imaging have enabled greater precision when it comes to targeting specific areas within a patient’s body – making it easier for clinicians to deliver treatments with greater accuracy & efficiency. This is especially important for liquid embolics given the required deployment depth & location which can vary from patient to patient depending on individual anatomy & characteristics.
In addition, technology such as 3D printing has become commonplace for creating customized catheters & guides tailored towards individual needs; this ensures consistent results regardless of each patient’s unique shape or size – alleviating many issues associated with traditional off-the-shelf catheter systems due to their inflexibility during deployment. Furthermore, new types of microcatheters are now available which allow delivery of smaller amounts of liquids directly into deep-seated vessels safely & accurately in order to precisely target focal lesions while avoiding healthy tissues around them.
- Meril Life Sciences Pvt Ltd.
- Johnson & Johnson
- Microvention Inc.
- Terumo Corporation
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/25513
Followed by new Product launches and approvals, agreements, collaborations and partnerships have emerged as key growth strategies adopted by liquid embolic product providers. By focusing on these strategies, key stakeholders are expanding their geographic footprint and strengthen their existing product portfolios across geographies.
In December 2020, Terumo Corporation announced that the WEB™ Embolization System, an intravascular aneurysm treatment device, has been launched in Japan.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/25513
Key Segments Covered in Liquid Embolic Industry Research
Liquid Embolic Market by Product
- Liquid Embolic Vials
- Liquid Embolic Prefilled Injectables
Liquid Embolic Market by Indication
- Brain Arterio-Venous Malformations (bAVM)
- Tumor Embolization
Liquid Embolic Market by End User
- Ambulatory Surgical Centers
- Independent Speciality Centres
Liquid Embolic Market by Region
- North America Liquid Embolic Market
- Latin America Liquid Embolic Market
- Europe Liquid Embolic Market
- East Asia Liquid Embolic Market
- South Asia Liquid Embolic Market
- Oceania Liquid Embolic Market
- Middle East & Africa (MEA) Liquid Embolic Market
Check out more Premium studies published by Persistence Market Research
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353